Navigation Links
Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand

Agency will lead public relations efforts to promote OTC cold and flu and allergy products

Los Angeles, CA (PRWEB) January 8, 2008 - Matrixx Initiatives, Inc., has selected GolinHarris as agency of record to lead its public relations initiatives for Zicam® LLC, a wholly owned subsidiary. The agency is charged with ongoing strategic counsel, product messaging, traditional media outreach and developing innovative social media programs. The account will be led out of the Los Angeles office by Negin Kamali, vice president, and Judy Johnson, regional managing director, with new media leadership from Scott Arenson, vice president of social media in the agency's Dialogue digital group. Zicam, one of the fastest growing over-the-counter cold products, is clinically proven to reduce the duration and severity of the common cold.
"We sought out an agency with a strong track record in consumer health products, traditional media relations and social media," said Bill Hemelt, Zicam's acting president. "We're especially excited about the work GolinHarris is doing for us in new media, including launching Zicam's first-ever mobile application for Google's new Android phone and the Apple iPhone, search engine optimization, as well as a number of social media applications."

"The cold and flu season is here and our work with Zicam is already in motion," said Judy Johnson, managing director of GolinHarris' western region. "The Cold and Flu Companion mobile application is just one of several strategies that we're employing to help consumers learn more about Zicam."

About Matrixx Initiatives
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly owned subsidiary, markets and sells Zicam® and Nasal ComfortTM products in the cough and cold category. The company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Swabs(TM); Zicam Cold Remedy ChewablesTM; Zicam Cold Remedy Oral MistTM; Zicam Cold Remedy RapidMeltsTM; Zicam Allergy Relief; Zicam Extreme Congestion Relief; Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at For investor information, contact Bill Barba, Treasurer, at 602-385-8881.

About GolinHarris
GolinHarris is a leading public relations agency offering a distinctive combination of global resources and personalized service in the Americas, Asia Pacific, Europe and the Middle East. Clients include Dow Chemical Company, McDonald's Corporation, Nintendo of America Inc., Orange, Texas Instruments and Toyota Motor Sales USA, Inc. GolinHarris celebrated its 50th anniversary in 2006, and is proud to have been selected as 2007 Agency of the Year by The Holmes Report, Large PR Agency of the Year in the PRWeek Awards, PRWeek Magazine's 2007 Editors' Choice and 2008 International Agency of the Year by PRCA. The agency is headquartered in Chicago and is part of the Interpublic Group of Companies (NYSE: IPG). For more information, visit or to join GolinHarris' discussion on the future of public relations, visit

Media Contact: Kathy Maiorana (312) 729-4246


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year
2. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2008 Financial Results
3. Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
5. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
6. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
7. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
8. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
9. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
10. Health Plans, Employers Take Closer Look at Costs and Expand Disease Management Initiatives in Response to Diabetes Prevalence Increase
11. Newly Reactivated Health Economics Research Institute to Launch New Initiatives for Improving Health Care Delivery
Post Your Comments:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology: